TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

84 hedge funds and large institutions have $455M invested in Trillium Therapeutics Inc. in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.

Holders
84
Holders Change
+19
Holders Change %
+29.23%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
30
Increased
24
Reduced
21
Closed
11
Calls
$9.19M
Puts
$3.35M
Net Calls
+$5.84M
Net Calls Change
+$4.59M

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$20.6M
2
PHS
2
PFM Health Sciences
California
$6.92M
3
GTC
3
Ghost Tree Capital
New York
$12.3M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$4.15M
5
O
5
OrbiMed
New York
$9.8M

Top Sellers

1
Deutsche Bank
1
Deutsche Bank
Germany
$137K
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$0
3
Millennium Management
3
Millennium Management
New York
$5.25M
4
VC
4
Vivo Capital
California
$0
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$1.51M
Name Market Value Shares Shares
Change 		Shares
Change %
VA
1
VR Adviser
New York
$54.9M 6,790,000 – –
RCM
2
RA Capital Management
Massachusetts
$49.9M 6,162,694 -198,752 -3%
NMC
3
NEA Management Company
Maryland
$46.4M 5,736,363 – –
ACA
4
Avoro Capital Advisors
New York
$38.4M 4,750,000 -200,000 -4%
BC
5
Boxer Capital
California
$33M 4,075,000 – –
Citadel Advisors
6
Citadel Advisors
Florida
$26.1M 3,222,464 -220,770 -6%
FM
7
Frazier Management
Washington
$22.3M 2,755,000 +311,191 +13%
EAM
8
Eventide Asset Management
Massachusetts
$20.6M 2,547,000 +2,547,000 New
MWNA
9
Marshall Wace North America
New York
$20.5M 2,533,789 -54,172 -2%
Franklin Resources
10
Franklin Resources
California
$12.4M 1,514,900 – –
GTC
11
Ghost Tree Capital
New York
$12.3M 1,525,000 +700,000 +85%
FFM
12
Fairmount Funds Management
Pennsylvania
$12M 1,483,181 -335,000 -18%
O
13
OrbiMed
New York
$9.8M 1,211,000 +410,000 +51%
SFM
14
Sphera Funds Management
Israel
$9.53M 1,178,346 -82,348 -7%
AG
15
Artal Group
Luxembourg
$7.71M 953,000 -47,000 -5%
PHS
16
PFM Health Sciences
California
$6.92M 855,270 +855,270 New
RSCM
17
Rock Springs Capital Management
Maryland
$6.17M 762,618 +12,618 +2%
ECM
18
Endurant Capital Management
California
$5.48M 677,823 +200,119 +42%
Millennium Management
19
Millennium Management
New York
$5.25M 648,853 -1,094,677 -63%
WP
20
Woodline Partners
California
$5.07M 626,810 -27,971 -4%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$4.15M 512,407 +512,407 New
Barclays
22
Barclays
United Kingdom
$3.92M 484,239 +353,069 +269%
TCM
23
Tekla Capital Management
Massachusetts
$3.63M 448,049 – –
SSA
24
Schonfeld Strategic Advisors
New York
$3.23M 399,500 +229,500 +135%
Renaissance Technologies
25
Renaissance Technologies
New York
$2.87M 355,321 +355,321 New
1
2 3 4